Francisco Ma. Fatima 4
4 · PROCTER & GAMBLE Co · Filed Mar 2, 2026
Research Summary
AI-generated summary of this filing
Procter & Gamble (PG) Exec Francisco Ma. Fatima Sells Shares
What Happened
- Francisco Ma. Fatima, CEO — Baby, Fem & Family Care at Procter & Gamble (PG), reported multiple open-market sales on Feb 27, 2026 totaling 5,549 shares disposed for about $917,199. The sales break down as 5,249 shares at $165.29 ($867,607), 130 shares at $165.30 ($21,489), 120 shares at $165.31 ($19,837) and 50 shares at $165.32 ($8,266). The report also shows an acquisition (derivative award) of 57.003 RSU-equivalent units on Feb 17, 2026 at $0.00 (no cash paid).
Key Details
- Transaction dates and prices:
- 2026-02-27 — Sale: 5,249 @ $165.29 = $867,607
- 2026-02-27 — Sale: 130 @ $165.30 = $21,489
- 2026-02-27 — Sale: 120 @ $165.31 = $19,837
- 2026-02-27 — Sale: 50 @ $165.32 = $8,266
- 2026-02-17 — Award (derivative): 57.003 units @ $0.00 (RSU-type)
- Total proceeds from Feb 27 sales: ≈ $917,199.
- Shares owned after the transactions: Not specified in the provided report.
- Footnotes of note:
- F1–F3 indicate the derivative units are dividend equivalents in the form of Restricted Stock Units (RSUs) and relate to the issuer’s retirement program; units convert to shares on retirement (or can be deferred).
- Filing: Report filed with SEC on 2026-03-02 for transactions through 2026-02-27; the filing shows no explicit late-filing flag in the provided data.
Context
- The reported dispositions were open-market sales (S). Sales are routine insider activity and do not, by themselves, prove a change in the insider’s view of the company.
- The smaller acquisition reported (A) is a derivative RSU award (dividend equivalents/retirement-related) and does not involve a cash purchase; such awards typically convert to shares on retirement or per plan rules.
Insider Transaction Report
Form 4
Francisco Ma. Fatima
CEO - Baby, Fem & Family Care
Transactions
- Sale
Common Stock
[F1]2026-02-27$165.29/sh−5,249$867,607→ 1,328.739 total - Sale
Common Stock
2026-02-27$165.30/sh−130$21,489→ 1,198.739 total - Sale
Common Stock
2026-02-27$165.31/sh−120$19,837→ 1,078.739 total - Sale
Common Stock
2026-02-27$165.32/sh−50$8,266→ 1,028.739 total - Award
Restricted Stock Units
[F2][F3]2026-02-17+57.003→ 888.761 total→ Common Stock (57.003 underlying)
Holdings
- 16,139.391(indirect: By Trust)
Common Stock
- 2,898.817(indirect: By Trust)
Common Stock
- 12,731(indirect: By SLAT)
Common Stock
Footnotes (3)
- [F1]Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.
- [F2]Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
- [F3]These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.
Signature
/s/ Wednesday Shipp, attorney-in-fact for Ma. Fatima Francisco|2026-03-02